1. Home
  2. ADV vs AQST Comparison

ADV vs AQST Comparison

Compare ADV & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Advantage Solutions Inc.

ADV

Advantage Solutions Inc.

HOLD

Current Price

$37.54

Market Cap

438.2M

ML Signal

HOLD

Logo Aquestive Therapeutics Inc.

AQST

Aquestive Therapeutics Inc.

HOLD

Current Price

$4.03

Market Cap

504.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADV
AQST
Founded
1987
2004
Country
United States
United States
Employees
73000
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
438.2M
504.0M
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
ADV
AQST
Price
$37.54
$4.03
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$45.83
$9.00
AVG Volume (30 Days)
83.7K
1.7M
Earning Date
05-06-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$67,430,000.00
Revenue This Year
$0.63
$10.08
Revenue Next Year
$0.45
$49.60
P/E Ratio
N/A
N/A
Revenue Growth
N/A
0.77
52 Week Low
$0.49
$2.68
52 Week High
$46.80
$7.55

Technical Indicators

Market Signals
Indicator
ADV
AQST
Relative Strength Index (RSI) 55.07 44.22
Support Level $1.00 $4.00
Resistance Level $46.80 $4.38
Average True Range (ATR) 3.42 0.20
MACD -0.53 -0.03
Stochastic Oscillator 48.13 6.07

Price Performance

Historical Comparison
ADV
AQST

About ADV Advantage Solutions Inc.

Advantage Solutions Inc provides outsourced sales, marketing, merchandising, sampling, and retailer support services to consumer packaged goods manufacturers and retailers across North America. Its services are designed to support distribution, retail execution, shopper engagement, and private brand development across both physical and digital commerce environments. The company serves various clients across grocery, mass, club, retail pharmacy, convenience, and other channels. It operates through three reportable segments: Branded Services, Experiential Services, and Retailer Services. The majority of the revenue is derived from the Experiential Services segment, which provides in-store and digital sampling programs, demonstrations, and experiential events for manufacturers and retailers.

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Share on Social Networks: